Alpo Vuorio (A Vuorio)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Low Density Lipoprotein

Particulate Matter

Men Who Have Sex With Men

Transcatheter Aortic Valve Replacement

Top Venues

Annals of medicine

Journal of internal medicine

Future virology

Disaster medicine and public health preparedness

This page only lists publications with an associated author ORCID identifier.

Publications

Alpo Vuorio, Bruce Budowle, Frederick J Raal, Petri T Kovanen
Statins for the prevention of cardiovascular events associated with avian influenza: the COVID-19 pandemic as a reference. Annals of medicine 56 (1) (2024)
Alpo Vuorio, Bruce Budowle, Frederick J Raal, Petri T Kovanen
Statins for the prevention of cardiovascular events associated with avian influenza: the COVID-19 pandemic as a reference. Annals of medicine 56 (1) (2024)
Alpo Vuorio, Bruce Budowle, Frederick J Raal, Petri T Kovanen
Statins for the prevention of cardiovascular events associated with avian influenza: the COVID-19 pandemic as a reference. Annals of medicine 56 (1) (2024)
Alpo Vuorio, Frederick J Raal, Petri T Kovanen
Extension of Heterozygous Familial Hypercholesterolemia Treatment Recommendations by Including Both Low-density Lipoprotein and Lipoprotein(a) Burden - a Unique Opportunity to Improve Patient Prognosis. European journal of preventive cardiology (2024)
Alpo Vuorio, Petri T Kovanen, Frederick J Raal
Coronary microcirculatory dysfunction in hypercholesterolemic patients with COVID-19: potential benefit from cholesterol-lowering treatment. Annals of medicine 55 (1) (2023)
Alpo Vuorio, Antti Sajantila, Petri T Kovanen, Bruce Budowle
MALEFICENT COMRADES: WAR IN UKRAINE AND COVID-19. Disaster medicine and public health preparedness (2022)
Alpo Vuorio, Jonas Brinck, Petri T Kovanen
Continuation of fibrate therapy in patients with metabolic syndrome and COVID-19: a beneficial regime worth pursuing. Annals of medicine 54 (1) (2022)
Alpo Vuorio, Petri T Kovanen, Frederick Raal
Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy. Future virology (2022)
Alpo Vuorio, Petri T Kovanen, Frederick J Raal
LETTER TO THE EDITOR. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Alpo Vuorio, Petri T Kovanen, Raul D Santos, Frederick Raal
Prevention of Cardiovascular Burden in COVID-19 Patients Suffering from Familial Hypercholesterolemia: A Global Challenge. Cardiology and therapy (2021)
Alpo Vuorio, Petri T Kovanen
Mucormycosis and glucose-regulated protein 78 in COVID-19: Amenable to statin treatment? Journal of internal medicine 290 (4) (2021)
Alpo Vuorio, Bruce Budowle, Petri T Kovanen
Airborne particles and cardiovascular morbidity in severe inherited hypercholesterolemia: Vulnerable endothelium under multiple attacks. BioEssays : news and reviews in molecular, cellular and developmental biology 44 (3) (2021)
Alpo Vuorio, Petri T Kovanen
Comment on: "Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry". Drugs 81 (9) (2021)
Alpo Vuorio, Gerald F Watts, Petri T Kovanen
Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk. Journal of internal medicine 287 (6) (2020)
Alpo Vuorio, G F Watts, W J Schneider, S Tsimikas, P T Kovanen
Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities. Journal of internal medicine 287 (1) (2020)
Alpo Vuorio, P T Kovanen
PCSK9 inhibitors for COVID-19: an opportunity to enhance the antiviral action of interferon in patients with hypercholesterolaemia. Journal of internal medicine 289 (5) (2020)